High-catalytic-activity glucanase mutant with improved thermal stability and application of high-catalytic-activity glucanase mutant

By performing site-directed mutation of the amino acid of glucanase, the high catalytic viable glucanase mutant M3 was obtained, which solved the problem of insufficient thermal stability of the existing β-glucanase and achieved high temperature under high temperature conditions Improves vitality and stability, suitable for industrial fields such as feed, beer brewing, etc.

CN118910012AActive Publication Date: 2024-11-08NANNING HARWORLD BIOLOGICAL TECH CORP

Patent Information

Application Number
CN202411071875.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-08
Estimated Expiration
2044-08-06

AI Technical Summary

Technical Problem

The thermal stability of existing β-glucanases is insufficient, making it difficult to meet the catalytic vitality needs under high temperature conditions in the industry, especially in the feed, beer brewing and food industries.

Method used

By performing point mutation of the amino acid of glucanase, the high catalytic viability glucanase mutant M3 was obtained, which enhanced its thermal stability above 50°C and its enzyme activity at acidic and neutral pH, including the following: The amino acids at positions 11, 209 and 228 undergo site-directed mutations.

Benefits of technology

The thermal stability of the mutant M3 at high temperatures is significantly improved, and the catalytic vitality is significantly improved. It can meet the needs of the feed industry and maintain high vitality within the temperature of 50-80℃ and pH range of 2.5-6.5, showing huge application potential. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910012A_ABST
    Figure CN118910012A_ABST
Patent Text Reader

Abstract

The invention discloses a glucanase mutant with improved thermal stability and high catalytic activity and application of the glucanase mutant, and belongs to the technical field of enzyme engineering. The amino acid sequence of the glucanase mutant M3 with improved thermal stability and high catalytic activity disclosed by the invention is as shown in SEQ ID NO.10. The invention further discloses a preparation method of the glucanase mutant M3 with improved thermal stability and high catalytic activity. The glucanase mutant with high catalytic activity, disclosed by the invention, is obtained by carrying out point mutation on wild amino acid of glucanase, can tolerate high-temperature treatment at 50 DEG C or above, and has very high enzyme activity under acidic and neutral pH; particularly, the method has very good application potential in the industrial fields of feed, beer brewing, food and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of enzyme engineering, and in particular to a high-catalytic-activity dextranase mutant with improved thermal stability and application thereof. Background Art

[0002] Dextranase is an important enzyme substance. Dextranase is usually derived from certain fungi or bacteria. It is produced by liquid deep fermentation and has the characteristics of acting specifically on the 1,3 and 1,4 glycosidic bonds of β-glucan. β-glucanase, as an enzyme that can decompose glucose polymers connected by β-glycosidic bonds, is divided into endo-type and exo-type according to its different mechanisms of action. Among them, a specific enzyme, endo-β-1,3-1,4-glucanase (EC3.2.1.73), has a unique decomposition ability. It can accurately act on the β-1,4 glycosidic bonds directly connected to the β-1,3 bonds, breaking them and decomposing them into smaller molecular weight fragments. This decomposition process not only reduces the hydrophilicity and viscosity of the substance, but also can significantly reduce the viscosity of the intestinal contents of monogastric animals. In addition, it also brings other positive effects, such as increasing the activity of endogenous digestive enzymes in animals, optimizing the microbial environment of the intestine, and thus improving the growth performance of animals and the conversion efficiency of feed. In short, this special β-glucanase improves the intestinal environment of animals through specific enzymatic action, promoting growth and improving feed utilization.

[0003] β-glucanase is widely used in the beer, bread, biomass degradation and other industries. It can specifically deconstruct β-glucan in a gentle and efficient manner, reducing its negative effects such as increased difficulty in the production process due to water retention, production impact, and increased costs. In the biomass degradation process, β-glucanase needs to maintain high catalytic activity under high temperature conditions; in the beer process, β-glucanase must remain stable in a wide temperature range of 40 to 70°C, and during bread fermentation, it must remain highly active at a specific temperature of 28 to 37°C for at least two hours. However, most of the β-glucanases reported so far have insufficient thermal stability and are difficult to meet industrial needs.

[0004] Improving the thermal stability and catalytic activity of glucanase is crucial for industrial applications, which not only broadens its scope of use, but also deepens the understanding of the relationship between enzyme structure and stability. However, endogenous β-glucanase in cereals is easily inactivated during high-temperature processes such as malting, saccharification and feed pelleting. In order to meet the needs of industrial production, it is necessary to modify the enzyme using protein engineering methods to improve its stability and promote the application of β-glucanase in industry. Summary of the invention

[0005] The purpose of the present invention is to provide a high catalytic activity dextranase mutant with improved thermal stability and its application, so as to solve the problems existing in the above-mentioned prior art. The high catalytic activity dextranase mutant of the present invention is obtained by point mutation of amino acids of the wild type dextranase, and the mutant can withstand high temperature treatment above 50°C, has very high enzyme activity at both acidic and neutral pH, and has good application potential in industrial fields such as feed, beer brewing and food.

[0006] To achieve the above object, the present invention provides the following solutions:

[0007] The present invention provides a high-catalytic activity glucanase mutant M3 with improved thermal stability. The amino acid sequence of the high-catalytic activity glucanase mutant M3 is shown in SEQ ID NO.10.

[0008] The present invention also provides a gene encoding the above-mentioned high catalytic activity glucanase mutant M3, and the nucleotide sequence of the gene is shown in SEQ ID NO.3.

[0009] The present invention also provides a recombinant vector, which contains the above gene.

[0010] The present invention also provides a recombinant microorganism, wherein the recombinant microorganism contains the recombinant vector.

[0011] The present invention also provides a method for constructing the above-mentioned high catalytic activity glucanase mutant M3, comprising the steps of performing site-directed mutagenesis on the amino acids at positions 11, 209 and 228 based on the wild type glucanase as shown in SEQ ID NO.2.

[0012] The present invention also provides the use of the above gene or the above recombinant vector or the above recombinant microorganism in producing a high-catalytic activity glucanase with improved thermal stability.

[0013] The present invention also provides the use of the high catalytic activity glucanase mutant M3 or the high catalytic activity glucanase mutant M3 constructed by the above construction method in degrading glucan, wherein the temperature during the degradation is 50-80° C. and the pH is 2.5-6.5.

[0014] The present invention discloses the following technical effects:

[0015] The present invention utilizes enzyme engineering means to improve the enzyme molecule of the wild-type glucanase to solve the disadvantage that the glucanase is easily inactivated during high temperature. After modification and optimization, the obtained mutant M3 has significantly improved thermal stability at high temperature and significantly improved catalytic activity, which can meet the requirements of feed enzymes. Therefore, the high-catalytic activity glucanase mutant M3 with improved thermal stability in the present invention shows great application potential in the feed industry. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0017] Figure 1 The results of the optimal temperature determination of the glucanase mutant M3 and the wild-type PaGlu16A;

[0018] Figure 2 is the half-life of the glucanase mutant M3 and wild-type PaGlu16A at 50°C (t 1 / 2 ) measurement results;

[0019] Figure 3 is the temperature stability of the glucanase mutant M3 and wild-type PaGlu16A (T 50 ) measurement results;

[0020] Figure 4 The results of the optimal pH determination of the glucanase mutant M3 and the wild-type PaGlu16A;

[0021] Figure 5 The results of pH stability test of glucanase mutant M3 and wild-type PaGlu16A. DETAILED DESCRIPTION

[0022] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0023] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0024] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.

[0025] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.

[0026] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0027] The materials that may be used in the embodiments of the present invention are as follows:

[0028] 1. Vectors and strains: The expression vector pPIC9r plasmid and Pichia pastoris GS115 were purchased from Invitrogen, and the Escherichia coli DMT competent cells were purchased from Quanshijin.

[0029] 2. Enzymes, kits and other biochemical reagents: Taq enzyme was purchased from TaKaRa, endonuclease and point mutation kit were purchased from Quanshijin, and substrate lichen polysaccharide was purchased from Magzyme. Other domestic analytical reagents were purchased from Sinopharm Reagent Company.

[0030] 3. Culture medium:

[0031] Escherichia coli LB medium: 1% peptone, 0.5% yeast extract, 1% NaCl, 1% agar powder (solid);

[0032] Yeast YPD medium: 2% glucose, 2% peptone, 1% yeast extract;

[0033] Yeast MD medium: 1.5% agarose, 2% glucose, biotin 4×10 -4 g / L, YNB 13.4 g / L;

[0034] Yeast BMGY medium: 2% peptone, 1% yeast extract, 1% glycerol (V / V), biotin 4×10 -4 g / L, YNB 13.4 g / L;

[0035] Yeast BMMY induction medium: 2% peptone, 1% yeast extract, YNB 13.4 g / L, 0.5% methanol (V / V), biotin 4×10 -4 g / L.

[0036] Example 1 Obtaining a gene encoding a high catalytic activity glucanase mutant and its recombinant expression vector

[0037] Using the GH16 family glucanase gene PaGlu16A (nucleotide sequence as shown in SEQ ID NO.1, amino acid sequence as shown in SEQ ID NO.2) from Polychaeton citri CBS116435 as a template, the N11Y, S209Q and G228P sites were subjected to site-directed mutagenesis by the site-directed mutagenesis method. The mutation method and cloning method were referred to the literature (Improvement of XYL10C_N catalytic performance through loop engineering for lignocellulosic biomass utilization in feed and fuel industries;You,et al.,2021), and the gene encoding the high catalytic activity glucanase mutant (nucleotide sequence as shown in SEQ ID NO.3) and its recombinant expression vector pPIC9r-M3 were obtained.

[0038] The primer information used is shown in Table 1:

[0039] Table 1 Primer information

[0040]

[0041] SEQ ID NO.1:

[0042] CAATACACCTTGGAAGATGACTACTTGGCTAATGGTTTCTTTGATCAATTTTCTTTCTTCACCTCTGGTGACCCAACTCATGGTTTCGTTCAATACGTTGATCAAGGTACCGCTAATTCTAACGGTTTGATTTCTTCTTCCGGTTCTCAAGCTGTTATGAGAGTTGATTCTACTAACACTGCTCCAAACGGTAGAACTTCTGTTAGATTGACTTCTAATAAGGCTTACGATTCTGGTTTGGTTATTGCTGATATTGCTCATATGCCTGGTGGTATTTGTGGTGTTTGGCCAGCTTTTTGGATGGTTGGTCCTAATTGGCCATCCAACGGAGAAATCGATATTATTGAAGGTGTTAATGACCAGTCTACTAACGATATGACTTTGCATACTTCTGATGGTTGTTCTATTGGTTCTGGTGGTATGTCTGGTTACGTTGTTACTTCTAATTGTTACATTAACGCTCCAGGTCAATCATCTAACCAAGGTTGTCAAATTGGAACCGGTGATACTTCTACTTACGGTTCTGGTTTTAATGCTAACGGTGGTGGTGTTTACGCTACTGAATTTACTTCTTCTGGTGTTAAGATTTTTTTCTTTCCAAGAGGTTCTATTCCTGGAGATATTTCTTCTGGTTCTCCTAATCCATCTTCTTGGGGTCAGCCAGTTGCTTACTTTCAAGGTGGTGGTTGTGATTTTGGTTCTCATATTAAGCAGCAACAAATTGTTTTCGATACTACTTTTTGTGGTGATTGGGCTGGTGCTGTTTGGGGTAATGGTGGTTGTGCTTCTAGAGCTGGTTCTTGTAACGATTTTGTTGCTAATAACCCTTCTGCTTTTTCTGATGCTTATTGGGCTGTTAATGGTTTGAAGGTTTATCAAAATTACGGTTCTACTTCTTTCGATTTGGAATCTCCACCATCTAACTCTTCTGCTTCTTCTTCTTCTGCTTCCGTTTTGAAGGAATCCAAGAAAGAAAGATTTAGAAGACATTTGGCTGAACATAGAAACTCTGGTGCTGAATTGTTT;

[0043] SEQ ID NO.2:

[0044] QYTLEDDYLANGFFDQFSFFTSGDPTHGFVQYVDQGTANSNGLISSSGSQAVMRVDSTNTAPNGRTSVRLTSNKAYDSGLVIADIAHMPGGICGVWPAFWMVGPNWPSNGEIDIIEGVNDQSTNDMTLHTSDGCSIGSGGMSGYVVTSNCYINAPGQSSNQGCQIGTGDTSTYGSGFNANGGGVYATEFTSSGVKIFFFPRGSIPGDISSGSPNPSSWGQPVAYFQGGGCDFGSHIKQQQIVFDTTFCGDWAGAVWGNGGCASRAGSCNDFVANNPSAFSDAYWAVNGLKVYQNYGSTSFDLESPPSNSSASSSSASVLKESKKERFRRHLAEHRNSGAELF;

[0045] SEQ ID NO.3:

[0046] CAATACACCTTGGAAGATGACTACTTGGCTTACGGTTTCTTTGATCAATTTTCTTTCTTCACCTCTGGTGACCCAACTCATGGTTTCGTTCAATACGTTGATCAAGGTACCGCTAATTCTAACGGTTTGATTTCTTCTTCCGGTTCTCAAGCTGTTATGAGAGTTGATTCTACTAACACTGCTCCAAACGGTAGAACTTCTGTTAGATTGACTTCTAATAAGGCTTACGATTCTGGTTTGGTTATTGCTGATATTGCTCATATGCCTGGTGGTATTTGTGGTGTTTGGCCAGCTTTTTGGATGGTTGGTCCTAATTGGCCATCCAACGGAGAAATCGATATTATTGAAGGTGTTAATGACCAGTCTACTAACGATATGACTTTGCATACTTCTGATGGTTGTTCTATTGGTTCTGGTGGTATGTCTGGTTACGTTGTTACTTCTAATTGTTACATTAACGCTCCAGGTCAATCATCTAACCAAGGTTGTCAAATTGGAACCGGTGATACTTCTACTTACGGTTCTGGTTTTAATGCTAACGGTGGTGGTGTTTACGCTACTGAATTTACTTCTTCTGGTGTTAAGATTTTTTTCTTTCCAAGAGGTTCTATTCCTGGAGATATTCAGTCTGGTTCTCCTTATCCATCTTCTTGGGGTCAGCCAGTTGCTTACTTTCAAGGTCCAGGTTGTGATTTTGGTTCTCATATTAAGCAGCAACAAATTGTTTTCGATACTACTTTTTGTGGTGATTGGGCTGGTGCTGTTTGGGGTAATGGTGGTTGTGCTTCTAGAGCTGGTTCTTGTAACGATTTTGTTGCTAATAACCCTTCTGCTTTTTCTGATGCTTATTGGGCTGTTAATGGTTTGAAGGTTTATCAAAATTACGGTTCTACTTCTTTCGATTTGGAATCTCCACCATCTAACTCTTCTGCTTCTTCTTCTTCTGCTTCCGTTTTGAAGGAATCCAAGAAAGAAAGATTTAGAAGACATTTGGCTGAACATAGAAACTCTGGTGCTGAATTGTTT.

[0047] Example 2 Preparation of high catalytic activity glucanase mutant

[0048] The recombinant expression vector pPIC9r-M3 obtained in Example 1 was linearized and digested with DMT enzyme, then transformed into Escherichia coli DMT competent cells, and verified by colony PCR to obtain a recombinant expression vector with a target site mutation. The vector was linearized with endonuclease BglⅡ and then electroporated into Pichia pastoris GS115 to obtain the recombinant yeast strain GS115 / M3.

[0049] The yeast strain GS115 / M3 containing the recombinant plasmid was inoculated into a 10 mL test tube containing 2 mL of BMGY medium, and cultured at 30°C, 220 rpm for 48 hours. The bacterial solution was centrifuged at 4500 rpm for 5 minutes, the supernatant was discarded, and the precipitate was resuspended in 2 mL of BMMY medium containing 0.5% methanol, and then induced and cultured again at 30°C, 220 rpm for 48 hours. The supernatant was taken for enzyme activity detection, and the yeast monoclone with the highest enzyme activity was screened.

[0050] The wild-type and screened mutant yeast strains were cultured and induced to produce enzymes. First, they were inoculated in 30 mL YPD medium at 30°C and 220 rpm shaking for 48 hours to obtain seed culture fluid, which was inoculated into a 1L Erlenmeyer flask containing 300 mL BMGY medium at 1% inoculation amount and cultured at 30°C and 220 rpm shaking for 48 hours; then the culture fluid was centrifuged for 5 minutes, the supernatant was discarded, the precipitate was resuspended in 200 mL BMMY medium containing 0.5% methanol, and then placed at 30°C and 220 rpm for induction culture for 48 hours. 1 mL of methanol was added every 12 hours, and the supernatant was taken for enzyme activity detection. Finally, the supernatant was concentrated to 30 mL, and the protein was purified by anion exchange method after desalting with disodium hydrogen phosphate-citrate buffer (pH 6.0, 10 mM) for enzymatic property determination and comparison. After the expressed enzyme was purified, its protein content reached more than 98% of the total protein, and was named M3. The amino acid sequence of the glucanase is shown in SEQ ID NO.10.

[0051] SEQ ID NO.10:

[0052] QYTLEDDYLAYGFFDQFSFFTSGDPTHGFVQYVDQGTANSNGLISSSGSQAVMRVDSTNTAPNGRTSVRLTSNKAYDSGLVIADIAHMPGGICGVWPAFWMVGPNWPSNGEIDIIEGVNDQSTNDMTLHTSDGCSIGSGGMSGYVVTSNCYINAPGQSSNQGCQIGTGDTS TYGSGFNANGGGVYATEFTSSGVKIFFFPRGSIPGDIQSGSPNPSSWGQPVAYFQGPGCDFGSHIKQQQIVFDTTFCGDWAGAVWGNGGCASRAGSCNDFVANNPSAFSDAYWAVNGLKVYQNYGSTSFDLESPPSNSSASSSSASVLKESKKERFRRHLAEHRNSGAELF.

[0053] Example 3 Comparative analysis of enzymatic properties of glucanase mutants and wild type

[0054] 1. DNS method for enzyme activity determination

[0055] The specific method is as follows: Under the optimal pH and temperature conditions, 100 μL of diluted enzyme solution (1 μg / mL) and 900 μL of substrate (0.5% lichen polysaccharide) were mixed, and after reacting for 10 minutes, 1.5 mL of DNS was added to terminate the reaction, and the mixture was boiled in boiling water for 5 minutes. After cooling, the OD was measured. 540 Under specific experimental conditions, the ability of an enzyme to hydrolyze glucan can be measured by the amount of reducing sugars produced. When glucan can be hydrolyzed and 1 micromole (μmoL) of reducing sugars can be produced per minute, the amount of enzyme used is defined as 1 enzyme activity unit (U).

[0056] 2. Determination of properties of mutant and wild-type glucanase

[0057] 1. Optimum temperature and thermal stability determination method

[0058] Method for determining the optimal temperature of glucanase: dissolve the substrate in 0.1 mol / L sodium dihydrogen phosphate-citrate buffer and perform enzymatic reaction at pH 4.0 and different temperatures (30-80°C). Figure 1 As shown, the optimum temperature of mutant M3 was 5°C higher than that of the wild type (50°C), and at high temperatures of 60°C to 80°C, the relative enzyme activity of mutant M3 (15.2%-79.9%) was 1.1-25.4 times higher than that of wild type PaGlu16A (0.7%-37.3%).

[0059] Half-life determination method: wild-type PaGlu16A and mutant M3 were treated at 50°C for a certain time (0-300 minutes), the protein concentration of all mutants and wild-type was 100 μg / mL, the volume was 100 μL, samples were taken at different time points and quickly placed on ice, and the residual enzyme activity was determined at 50°C and pH 4.0. Figure 2 As shown, in terms of thermal stability, the half-life of mutant M3 at 50°C was 232 min, which was 158 min longer than that of the wild type (74 min).

[0060] 2. Temperature stability T 50 Temperature stability is the activity remaining at half of the original temperature after 30 min of treatment (T 50 The wild type and mutants were heat-incubated at a specific temperature of 45-75°C without substrate for 30 min. Figure 3 As shown, the T of wild-type PaGlu16A was measured 50 The value was 55.0℃, while the T of mutant M3 was 50 The value increased by 10.0°C compared with the wild type, reaching up to 65.0°C. Moreover, when treated at 60°C, the wild type lost more than 90% of its activity, while the mutant M3 retained 83.4% of its initial activity.

[0061] 3. Optimal pH and pH stability determination method

[0062] The pH properties of wild-type PaGlu16A and its mutant M3 were evaluated from the perspectives of optimal pH and pH stability. Enzymatic reactions were performed at different pH values ​​(1.0-7.0) to determine the optimal pH. The substrate lichen polysaccharide was dissolved in 0.1 mol / L sodium dihydrogen phosphate-citric acid buffer at different pH values ​​at 50°C for enzyme activity determination; the enzyme solution was incubated at 37°C in buffers of different pH values ​​(1.0-12.0) for 1 hour, and the residual enzyme activity was determined to show the pH stability of the enzyme.

[0063] The results are as follows Figure 4 As shown in Figure 2, the optimum pH for both the wild type and the mutant is 4.0, and the mutant can maintain more than 40% relative enzyme activity between pH 2.5 and 6.5. Figure 5 As shown, the pH stability of the mutant in the solution environment at pH 6.0-9.0 is significantly better than that of the wild type. For example, at pH 9.0, the relative enzyme activity of the mutant is above 80%, while that of the wild type is only 32%.

[0064] 4. Determination of kinetic parameters and specific activity of glucanase

[0065] The detection method was referred to the literature (Improvement of enzyme activity ofβ-1,3-1,4-glucanasefrom Paenibacillus sp.X4 by error-prone PCR and structural insights ofmutated residues.DOI 10.1007 / s00253-017-8145-4,Baek et al.,2017) to determine the first-order reaction time of the reaction. m Value and V max The reaction time was 5 min. Different concentrations of dextran (0.625, 0.5, 0.4, 0.2, 0.1, 0.075 and 0.05 mg / mL) were used as substrates. The enzyme activity was measured under standard conditions (50°C, pH 4.0), and the corresponding reaction rate was calculated. K was calculated using GraFit7 software. m Value and V max .

[0066] As shown in Table 2, compared with the wild type, the binding ability of mutant M3 to the substrate was significantly enhanced (K m The values ​​were 37.9% and 45.2% lower than those of the wild type, respectively. When barley glucan was used as substrate, the catalytic efficiency (k cat / K m ) was 29% higher than the wild type. The specific activity of mutant M3 was not significantly lower than that of the wild type. When lichen polysaccharide was used as substrate, the catalytic efficiency of mutant M3 (3100 mL / s·mg) was 48% higher than that of the wild type (2100 mL / s·mg).

[0067] Table 2 Specific activity and catalytic efficiency of wild-type and mutant glucanase

[0068]

[0069] Note: Kinetic values ​​are shown as mean standard deviation (n=3).

[0070] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A high catalytic activity glucanase mutant M3 with improved thermal stability, characterized in that: The amino acid sequence of the high catalytic activity glucanase mutant M3 is shown in SEQ ID NO.

10.

2. A gene encoding the high catalytic activity glucanase mutant M3 according to claim 1, characterized in that: The nucleotide sequence of the gene is shown in SEQ ID NO.

3.

3. A recombinant vector, characterized in that: The recombinant vector contains the gene according to claim 2.

4. A recombinant microorganism, characterized in that The recombinant microorganism contains the recombinant vector according to claim 3.

5. A method for constructing the high catalytic activity glucanase mutant M3 according to claim 1, characterized in that: The method comprises the steps of performing site-directed mutation on the amino acids at positions 11, 209 and 228 based on the wild type of glucanase as shown in SEQ ID NO.

2.

6. Use of the gene according to claim 2, the recombinant vector according to claim 3, or the recombinant microorganism according to claim 4 in producing a high-catalytic activity glucanase with improved thermal stability.

7. Use of the high catalytic activity dextranase mutant M3 according to claim 1 or the high catalytic activity dextranase mutant M3 constructed by the construction method according to claim 5 in degrading dextran, characterized in that: The temperature during the degradation is 50-80° C., and the pH is 2.5-6.5.

Citation Information

Patent Citations

  • Glycan polymers and related methods thereof

    CN110267663A

  • GH16 family heat-resistant glucanase mutant as well as construction method and application thereof

    CN112481240A

  • Group of N-glycosylation mutants of GH16 family glucanase and application of N-glycosylation mutants

    CN113416721A

  • Glucanase mutant and application thereof

    CN114381448A

  • GH16 family heat stability enhanced glucanase mutant as well as construction method and application thereof

    CN114836402A

Cited By

  • Method for improving high-temperature catalytic activity of alpha-glucan phosphorylase, mutant Tp alpha GPR673A, gene and application

    CN120442584A